Sandra Gass is a highly educated professional with a wealth of experience in the biotechnology and pharmaceutical industries. She holds a degree in Engineer in Biotechnology, Molecular Biology, Biotechnology from Ecole Supérieure de Biotechnologie de Strasbourg and a Doctor of Philosophy in Molecular Biology from Université de Lausanne. Gass has held several prominent positions throughout her career, including International Commercial Assessment and Business Development Lead - New Product Strategy and Director International Marketing PNH at Alexion Pharma GmbH. She has also worked as a Senior Medical Marketing Manager at Alexion Pharma GmbH and as a Medical Advisor for Multiple Sclerosis Switzerland at Novartis Pharma Switzerland.
Gass began her career as a Research Assistant at Cold Spring Harbor Laboratory and later became a PhD Fellow at the Swiss Institute for Experimental Cancer Research. She also studied Strategies for Leadership at IMD Business School to further develop her skills as a leader in her field.
Gass's expertise lies in medical and scientific research, rare diseases, and pharmaceutical marketing. She has a passion for utilizing her knowledge and experience to create successful business strategies that improve the lives of patients worldwide.